<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/41FE8906-8021-4235-AC80-E6BE69EEACD3"><gtr:id>41FE8906-8021-4235-AC80-E6BE69EEACD3</gtr:id><gtr:name>MRC ING Keneba and LSHTM</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E5A97C6C-5CB2-4250-A23A-1717C0941336"><gtr:id>E5A97C6C-5CB2-4250-A23A-1717C0941336</gtr:id><gtr:name>Weatherall Institute of Molecular Med</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX3 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/41FE8906-8021-4235-AC80-E6BE69EEACD3"><gtr:id>41FE8906-8021-4235-AC80-E6BE69EEACD3</gtr:id><gtr:name>MRC ING Keneba and LSHTM</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E5A97C6C-5CB2-4250-A23A-1717C0941336"><gtr:id>E5A97C6C-5CB2-4250-A23A-1717C0941336</gtr:id><gtr:name>Weatherall Institute of Molecular Med</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX3 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/10560645-34E8-4617-A3C3-4C40175F363E"><gtr:id>10560645-34E8-4617-A3C3-4C40175F363E</gtr:id><gtr:firstName>Hal</gtr:firstName><gtr:surname>Drakesmith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700844"><gtr:id>4148ABAF-A203-45FE-961D-F18E5175D110</gtr:id><gtr:title>Interactions between HIV-1 and iron</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700844</gtr:grantReference><gtr:abstractText>Infection with HIV-1 leads to AIDS. Around the world, the number of people infected with HIV-1 is increasing, and current forms of medicine do not adequately control the spread of the virus. There are clues in previous scientific studies suggesting that HIV-1 needs iron to grow efficiently, and we have found evidence that HIV-1 itself manipulates people?s cells in order to obtain this iron. The research proposal has two parts; the first is to find out how HIV-1 affects the handling of iron by infected cells. The second is to find out if deliberately altering how infected cells obtain iron can reduce the spread of HIV-1. Together the two sections should increase our understanding of the HIV-1/AIDS problem and may suggest more effective methods of controlling the virus.</gtr:abstractText><gtr:technicalSummary>HIV-1 infections continue to increase; new methods of controlling HIV-1 are desirable. Iron deposits in macrophages are frequently observed in HIV-1 infected patients, and the amount of iron correlates with mortality. Iron favours HIV-1 replication through various mechanisms including NFkappaB activation and nucleotide synthesis. Previously we found the Nef protein of HIV-1 interacts with the macrophage expressed haemochromatosis protein HFE, indicating HIV-1 actively modulates iron metabolism for its own benefit. The first section of this proposal is to study precisely how HIV-1 alters iron transport by macrophages. Macrophages acquire iron from serum transferrin and haemoglobin, and recycle 30mg/day iron into the blood to supply the bone marrow. The iron is released back into serum by the iron efflux protein ferroportin, which is held in check by its inhibitor peptide, the key iron regulatory hormone hepcidin. Experiments will test how HIV-1 affects macrophage iron uptake from transferrin and haemoglobin, iron release via ferroportin, and if HIV-1 regulates the synthesis of hepcidin. The second complementary section of the proposal investigates if modulating macrophage iron levels experimentally affects HIV-1 replication. In particular a panel of iron chelators will be used to in an attempt to reduce HIV-1 growth while not adversely influencing cell viability. The overall aim of the project is to understand how HIV-1 and macrophage iron transport influence each other, and the data obtained may suggest new types of intervention to reduce HIV-1 growth.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-11</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-02-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>247690</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC ING Keneba and LSHTM</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HIGH Consortium</gtr:description><gtr:id>88039F40-EEE3-436A-9228-121E2C1238B5</gtr:id><gtr:impact>grant from the Bill and Melinda Gates Foundation</gtr:impact><gtr:partnerContribution>direction of research, field studies</gtr:partnerContribution><gtr:piContribution>Hepcidin measurement, oversight of research, direction of research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC International Nutrition Group</gtr:department><gtr:description>investigating iron in infectious diseases</gtr:description><gtr:id>C5B659FB-B02C-4BC8-B620-F25089572023</gtr:id><gtr:impact>18552864</gtr:impact><gtr:partnerContribution>more opportunity to access patient samples to measure desired parameters, in order to assess how disease outcome correlates with iron status.</gtr:partnerContribution><gtr:piContribution>measured hepcidin in sera of infected patients</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weatherall Institute of Molecular Medicine (WIMM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Borrow Lab</gtr:department><gtr:description>measuring hepcidin in acute viral infections</gtr:description><gtr:id>B28813D8-3C40-4AD3-B78D-5219BBEA41DB</gtr:id><gtr:impact>publications in preparation</gtr:impact><gtr:partnerContribution>they provided the samples and helped do the measurements</gtr:partnerContribution><gtr:piContribution>we measured hepcidin in samples from individuals with acute viral infections and correlated these with acute phase proteins and cytokines</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BF948392-0032-4E6F-8E44-F44BE4C144B6</gtr:id><gtr:impact>30 pupils attended a talk about infectious diseases, which led to intense and close questioning of the presenter.

The presenter has been invited back and been invited to sister schools.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit, Ardingley College Sussex</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>18F0E1D3-C036-4008-B4A5-78F31AEE19F7</gtr:id><gtr:impact>Seminar and interactive discussion on HIV/AIDS with 6th form students

favourable mention in an OFSTED inspection report that happened to be occurring at the same time!</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>460000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IRON METABOLISM AND MALARIAL PATHOGENESIS</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3FC281A9-F65C-4C35-B458-BA3879BA3AD2</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development Award</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>CORE Charity</gtr:fundingOrg><gtr:id>EC9588C8-9942-489F-BAC3-05D80D337966</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Gates Foundation Global Health Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1055865</gtr:fundingRef><gtr:id>533C8AC5-FCAD-4B4F-9156-FC1E3FC6BEF9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Pilot Award</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>5859CFA1-E161-4671-ABFA-CE03F0FA3626</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Isis Innovation</gtr:department><gtr:description>Oxford Invention Fund</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>A8525CBD-5A8C-4494-A4D4-43F5E6ADC5A8</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have modified and optimised a commercially available Elisa kit to measure hepcidin, the master regulator of iron metabolism, in human serum / plasma</gtr:description><gtr:id>9BECCFC3-DC5C-444B-AA18-8CF457F2453A</gtr:id><gtr:impact>Blood. 2012 Feb 23;119(8):1922-8. Epub 2012 Jan 6.
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children.
Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H.
and other publications Atkinson et al Blood 2014; Pasricha et al Sci Transl Med 2014; Armitage et al PNAS 2014

Gates Foundation Global Health Grant to study use of hepcidin to guide iron supplementation</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>serum hepcidin measurement</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/480499B1-873C-43C4-AE20-CA1A464F6F12"><gtr:id>480499B1-873C-43C4-AE20-CA1A464F6F12</gtr:id><gtr:title>Reflecting on a quarter century of HIV research.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CBC02D1-044F-44A2-B20E-6DD50AAD53FA"><gtr:id>2CBC02D1-044F-44A2-B20E-6DD50AAD53FA</gtr:id><gtr:title>Viral infection and iron metabolism.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/461E6459-EC6A-4EE7-B860-A185DB6F971A"><gtr:id>461E6459-EC6A-4EE7-B860-A185DB6F971A</gtr:id><gtr:title>Plasmodium falciparum infected erythrocytes induce hepcidin (HAMP) mRNA synthesis by peripheral blood mononuclear cells.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21D38385-3A37-46FD-B661-FBDA5672C5BC"><gtr:id>21D38385-3A37-46FD-B661-FBDA5672C5BC</gtr:id><gtr:title>Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07A09D93-A7DA-4DDD-B2F0-91E518B0A3D0"><gtr:id>07A09D93-A7DA-4DDD-B2F0-91E518B0A3D0</gtr:id><gtr:title>Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cbf202e1cd4288aceb44ec51fda97ce8"><gtr:id>cbf202e1cd4288aceb44ec51fda97ce8</gtr:id><gtr:otherNames>Darton TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A164CD6-5597-40D4-9EC3-83D1A1CECC90"><gtr:id>5A164CD6-5597-40D4-9EC3-83D1A1CECC90</gtr:id><gtr:title>Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7023A987-F6D2-4422-AD75-9286F105CC47"><gtr:id>7023A987-F6D2-4422-AD75-9286F105CC47</gtr:id><gtr:title>Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.</gtr:title><gtr:parentPublicationTitle>The Journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3166</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB4ECF16-92FA-47FF-8669-9CF573F6690B"><gtr:id>EB4ECF16-92FA-47FF-8669-9CF573F6690B</gtr:id><gtr:title>Hepcidin and the iron-infection axis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83075959-8BC4-4841-9515-5E59D76412FB"><gtr:id>83075959-8BC4-4841-9515-5E59D76412FB</gtr:id><gtr:title>Hepcidin regulation by innate immune and infectious stimuli.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66C48A71-07E3-4492-9123-64A472089DD1"><gtr:id>66C48A71-07E3-4492-9123-64A472089DD1</gtr:id><gtr:title>Ironing out Ferroportin.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0DEA0101-B3D4-46DC-95B8-F1F59D63B5DE"><gtr:id>0DEA0101-B3D4-46DC-95B8-F1F59D63B5DE</gtr:id><gtr:title>Intravenous iron and vertical HIV transmission: any connection?</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0face8aeeccf25b3c835e913f610d8f3"><gtr:id>0face8aeeccf25b3c835e913f610d8f3</gtr:id><gtr:otherNames>Thompson F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700844</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>